255 related articles for article (PubMed ID: 33137376)
21. Myeloperoxidase-derived hypochlorous acid promotes ox-LDL-induced senescence of endothelial cells through a mechanism involving β-catenin signaling in hyperlipidemia.
Liu WQ; Zhang YZ; Wu Y; Zhang JJ; Li TB; Jiang T; Xiong XM; Luo XJ; Ma QL; Peng J
Biochem Biophys Res Commun; 2015 Nov; 467(4):859-65. PubMed ID: 26474698
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant binding of caeruloplasmin to myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact.
Park YS; Suzuki K; Mumby S; Taniguchi N; Gutteridge JM
Free Radic Res; 2000 Sep; 33(3):261-5. PubMed ID: 10993479
[TBL] [Abstract][Full Text] [Related]
23. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases.
Zhang C; Yang J; Jacobs JD; Jennings LK
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2563-72. PubMed ID: 14613914
[TBL] [Abstract][Full Text] [Related]
24. Myeloperoxidase and its contributory role in inflammatory vascular disease.
Lau D; Baldus S
Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
[TBL] [Abstract][Full Text] [Related]
25. Myeloperoxidase in kidney disease.
Malle E; Buch T; Grone HJ
Kidney Int; 2003 Dec; 64(6):1956-67. PubMed ID: 14633118
[TBL] [Abstract][Full Text] [Related]
26. Myeloperoxidase-mediated protein lysine oxidation generates 2-aminoadipic acid and lysine nitrile in vivo.
Lin H; Levison BS; Buffa JA; Huang Y; Fu X; Wang Z; Gogonea V; DiDonato JA; Hazen SL
Free Radic Biol Med; 2017 Mar; 104():20-31. PubMed ID: 28069522
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
Pekoe G; Van Dyke K; Mengoli H; Peden D; English D
Agents Actions; 1982 Apr; 12(1-2):232-8. PubMed ID: 6282074
[TBL] [Abstract][Full Text] [Related]
28. MPO (Myeloperoxidase) Reduces Endothelial Glycocalyx Thickness Dependent on Its Cationic Charge.
Manchanda K; Kolarova H; Kerkenpaß C; Mollenhauer M; Vitecek J; Rudolph V; Kubala L; Baldus S; Adam M; Klinke A
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1859-1867. PubMed ID: 29903730
[TBL] [Abstract][Full Text] [Related]
29. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
Vlasova II; Sokolov AV; Arnhold J
J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.
Cheng D; Talib J; Stanley CP; Rashid I; Michaëlsson E; Lindstedt EL; Croft KD; Kettle AJ; Maghzal GJ; Stocker R
Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1448-1457. PubMed ID: 31043077
[TBL] [Abstract][Full Text] [Related]
31. The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease.
Davies MJ; Hawkins CL
Antioxid Redox Signal; 2020 May; 32(13):957-981. PubMed ID: 31989833
[No Abstract] [Full Text] [Related]
32. Leukocyte-derived myeloperoxidase amplifies high-glucose--induced endothelial dysfunction through interaction with high-glucose--stimulated, vascular non--leukocyte-derived reactive oxygen species.
Zhang C; Yang J; Jennings LK
Diabetes; 2004 Nov; 53(11):2950-9. PubMed ID: 15504976
[TBL] [Abstract][Full Text] [Related]
33. Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism.
Stocker R; Huang A; Jeranian E; Hou JY; Wu TT; Thomas SR; Keaney JF
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2028-33. PubMed ID: 15331437
[TBL] [Abstract][Full Text] [Related]
34. Myeloperoxidase-derived damage to human plasma fibronectin: Modulation by protein binding and thiocyanate ions (SCN
Vanichkitrungruang S; Chuang CY; Hawkins CL; Davies MJ
Redox Biol; 2020 Sep; 36():101641. PubMed ID: 32863239
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide modulates the catalytic activity of myeloperoxidase.
Abu-Soud HM; Hazen SL
J Biol Chem; 2000 Feb; 275(8):5425-30. PubMed ID: 10681518
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents.
Maiocchi SL; Morris JC; Rees MD; Thomas SR
Biochem Pharmacol; 2017 Jul; 135():90-115. PubMed ID: 28344126
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase mediated alteration of endothelial function is dependent on its cationic charge.
Kolářová H; Víteček J; Černá A; Černík M; Přibyl J; Skládal P; Potěšil D; Ihnatová I; Zdráhal Z; Hampl A; Klinke A; Kubala L
Free Radic Biol Med; 2021 Jan; 162():14-26. PubMed ID: 33271281
[TBL] [Abstract][Full Text] [Related]
38. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2009 May; 22(5):807-17. PubMed ID: 19326902
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase instigates proinflammatory responses in a cecal ligation and puncture rat model of sepsis.
Yu H; Liu Y; Wang M; Restrepo RJ; Wang D; Kalogeris TJ; Neumann WL; Ford DA; Korthuis RJ
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H705-H721. PubMed ID: 32762560
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides.
Rees MD; Bottle SE; Fairfull-Smith KE; Malle E; Whitelock JM; Davies MJ
Biochem J; 2009 Jun; 421(1):79-86. PubMed ID: 19379130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
